Piotr Ponikowski

Also affiliated with Indiana University Hospital, John Radcliffe Hospital, University Medical Center, Fraunhofer Institute for Microengineering and Microsystems, Wroclaw Medical University, Heart Foundation, Uczelnia Korczaka – Akademia Nauk Stosowanych, Silesian Center for Heart Disease, Central Clinical Hospital, University of Business in Wrocław

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 39 papers. Top paper: “Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes”.

Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes

JAMA(2020)10.1001/jama.2020.1906

N/A

6.7DataRank · unranked

539 citations

Subodh Verma, Kieran F. Docherty, Silvio E. Inzucchi, Inder S. Anand, Jan Bělohlávek +34 more

Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction

JAMA(2020)10.1001/jama.2020.15922

N/A

5.3DataRank · unranked

278 citations

Carolyn S.P. Lam, Kevin J. Anstrom, Justin A. Ezekowitz, Adrian F. Hernandez, Christopher M. O’Connor +14 more

Effect of Dapagliflozin in Patients With HFrEF Treated With Sacubitril/Valsartan

JACC Heart Failure(2020)10.1016/j.jchf.2020.04.008

N/A

5.0DataRank · unranked

142 citations

Pardeep S. Jhund, Brian Claggett, Pooja Dewan, Lars Køber, Mikhail Kosiborod +11 more

Initial Decline (Dip) in Estimated Glomerular Filtration Rate After Initiation of Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: Insights From DAPA-HF

Circulation(2022)10.1161/circulationaha.121.058910

N/A

4.7DataRank · unranked

131 citations

Kieran F. Docherty, Hiddo J.L. Heerspink, Rudolf A. de Boer, Kevin Damman, Silvio E. Inzucchi +16 more

Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis From DAPA-HF

Diabetes Care(2020)10.2337/dc20-1675

N/A

2.7DataRank · unranked

76 citations

Kieran F. Docherty, Lars Køber, Mikhail Kosiborod, Felipe A. Martínez, Piotr Ponikowski +16 more

Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction: An Analysis of DAPA-HF

Circulation(2021)10.1161/circulationaha.121.053659

N/A

2.5DataRank · unranked

60 citations

Piotr Ponikowski, Kieran F. Docherty, Samvel B. Gasparyan, Michael Böhm, Chern‐En Chiang +16 more

Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: an analysis of DAPA‐HF

European Journal of Heart Failure(2020)10.1002/ejhf.2083

N/A

1.7DataRank · unranked

48 citations

Kieran F. Docherty, Olof Bengtsson, Rudolf A. de Boer, Akshay S. Desai, Jarosław Dróżdż +19 more

Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER

Circulation(2022)10.1161/circulationaha.122.062832

N/A

1.5DataRank · unranked

56 citations

Muthiah Vaduganathan, Brian Claggett, Sheila M. Hegde, Maria Pabón, Ian J. Kulac +22 more

2013 ESH/ESC Guidelines for the management of arterial hypertension

European Heart Journal(2013)10.1093/eurheartj/eht151

N/A

1.4DataRank · unranked

13664 citations

Robert Fagard, Krzysztof Narkiewicz, Josep Redón, Alberto Zanchetti, Michael Böhm +86 more

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

European Heart Journal(2016)10.1093/eurheartj/ehw128

N/A

1.4DataRank · unranked

11440 citations

Adriaan A. Voors, Stefan D. Anker, Héctor Bueno, John G F Cleland, Andrew J S Coats +16 more

2018 ESC/ESH Guidelines for the management of arterial hypertension

European Heart Journal(2018)10.1093/eurheartj/ehy339

N/A

1.4DataRank · unranked

10320 citations

Giuseppe Mancia, Wilko Spiering, Enrico Agabiti Rosei, Michel Azizi, Michel Burnier +171 more

Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial

The Lancet(2025)10.1016/s0140-6736(25)01665-4

N/A

1.3DataRank · unranked

71 citations

Ciaran J. McMullan, Kevin J. Anstrom, Irina Barash, Marc P. Bonaca, Maria Borentain +94 more

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC

European Heart Journal(2012)10.1093/eurheartj/ehs104

N/A

1.3DataRank · unranked

6898 citations

J. J. V. McMurray, S. Adamopoulos, S. D. Anker, M. Bohm, V. Falk +103 more

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

European Heart Journal(2016)10.1093/eurheartj/ehw210

N/A

1.3DataRank · unranked

6424 citations

Stefano Benussi, Dipak Kotecha, Anders Ahlsson, Dan Atar, Barbara Casadei +54 more

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

New England Journal of Medicine(2019)10.1056/nejmoa1911303

N/A

1.3DataRank · unranked

5622 citations

Scott D. Solomon, Silvio E. Inzucchi, Lars Køber, Mikhail N. Kosiborod, Felipe A. Martinez +43 more

Patient Characteristics, Clinical Outcomes, and Effect of Dapagliflozin in Relation to Duration of Heart Failure

Circulation Heart Failure(2020)10.1161/circheartfailure.120.007879

N/A

1.1DataRank · unranked

27 citations

Pooja Dewan, Pardeep S. Jhund, Silvio E. Inzucchi, Lars Køber, Mikhail Kosiborod +9 more

Association of Early Blood Pressure Decrease and Renal Function With Prognosis in Acute Heart Failure

JACC Heart Failure(2021)10.1016/j.jchf.2021.07.001

N/A

1.1DataRank · unranked

24 citations

Iziah E Sama, Douwe Postmus, Marco Metra, Barry Greenberg, Gad Cotter +10 more

Vericiguat and Health-Related Quality of Life in Patients With Heart Failure With Reduced Ejection Fraction: Insights From the VICTORIA Trial

Circulation Heart Failure(2022)10.1161/circheartfailure.121.009337

N/A

1.1DataRank · unranked

43 citations

Amanda Stebbins, Vojtěch Melenovský, Nancy K. Sweitzer, Martín Cowie, Josef Stehlik +15 more

Relationship of Dapagliflozin With Serum Sodium

JACC Heart Failure(2022)10.1016/j.jchf.2022.01.019

N/A

0.999DataRank · unranked

31 citations

Kieran F. Docherty, Pardeep S. Jhund, Mark C. Petrie, Silvio E. Inzucchi, Lars Køber +12 more

Cause of Death in Patients With Acute Heart Failure

JACC Heart Failure(2020)10.1016/j.jchf.2020.09.010

N/A

0.970DataRank · unranked

24 citations

John R. Teerlink, Marco Metra, Larry A. Allen, Javed Butler, Peter E. Carson +17 more

Efficacy of Dapagliflozin in Black Versus White Patients With Heart Failure and Reduced Ejection Fraction

JACC Heart Failure(2021)10.1016/j.jchf.2021.08.006

N/A

0.900DataRank · unranked

49 citations

Modele O. Ogunniyi, Inder S. Anand, Akshay S. Desai, Mirta Díez, Jonathan G. Howlett +17 more

Effect of Dapagliflozin, Compared With Placebo, According to Baseline Risk in DAPA-HF

JACC Heart Failure(2022)10.1016/j.jchf.2021.09.002

N/A

0.614DataRank · unranked

13 citations

Joanne Simpson, Pardeep S. Jhund, Silvio E. Inzucchi, Lars Køber, Mikhail Kosiborod +10 more

Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of CRD-740, a PDE9 Inhibitor, in Chronic Heart Failure

JACC Heart Failure(2025)10.1016/j.jchf.2025.102706

N/A

0.208DataRank · unranked

3 citations

Jan Bělohlávek, Andrej Dukát, Justin A. Ezekowitz, Sorel Goland, Béla Merkely +14 more

Prediction and Longer-Term Outcomes of All-cause and Cardiovascular Mortality in the HEART-FID Trial

Journal of Cardiac Failure(2025)10.1016/j.cardfail.2025.01.009

N/A

0.208DataRank · unranked

3 citations

Hillary Mulder, Robert J. Mentz, Javed Butler, Carmine G. De Pasquale, Gregory D. Lewis +10 more

Update on Preclinical Models of Cancer Therapy-Related Cardiac Dysfunction: Challenges and Perspectives. A Scientific Statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-Oncology, and the ESC Working Group on Cellular Biology of the Heart

European Journal of Heart Failure(2025)10.1002/ejhf.3636

N/A

0DataRank · unranked

12 citations

Pietro Ameri, Aarti Asnani, Edoardo Bertero, Rudolf A. de Boer, Dimitrios Farmakis +18 more

Reprieve System for the Treatment of Patients With Acute Decompensated Heart Failure

Journal of Cardiac Failure(2025)10.1016/j.cardfail.2025.02.002

N/A

0DataRank · unranked

3 citations

Veena Rao, Tamaz Shaburishvili, Ivlita Verulava, Nino Khabeishvili, Mark C. Petrie +9 more

Empagliflozin After Myocardial Infarction with or without diabetes and chronic kidney disease: Insights from EMPACT-MI

ESC Heart Failure(2025)10.1002/ehf2.15393

N/A

0DataRank · unranked

1 citations

Javed Butler, Jacob A. Udell, W. Schuyler Jones, Mark C. Petrie, Josephine Harrington +19 more

Sodium–glucose co‐transporter 2 inhibition in patients hospitalized for acute decompensated heart failure: rationale for and design of the EMPULSE trial

European Journal of Heart Failure(2021)10.1002/ejhf.2137

N/A

0DataRank · unranked

103 citations

Piotr Ponikowski, Afshin Salsali, Christiane E. Angermann, Jan Biegus, Jon Blatchford +10 more

Assessing Benefit in Heart Failure Patients with Reduced Ejection Fraction: Analysis of the VICTORIA Trial Using Novel Prognostic Risk Stratification

medRxiv(2025)10.1101/2025.04.03.25325054

N/A

0DataRank · unranked

0 citations

Sarah Rathwell, Devan V. Mehrotra, Stefano Corda, Ciaran J. McMullan, Carolyn S.P. Lam +13 more

Compensatory post-diuretic renal sodium reabsorption is not a dominant mechanism of diuretic resistance in acute heart failure

European Heart Journal(2021)10.1093/eurheartj/ehab620

N/A

0DataRank · unranked

34 citations

Veena S. Rao, Juan B. Ivey‐Miranda, Julieta Moreno-Villagómez, Devin Mahoney, Piotr Ponikowski +11 more

Neutrophil-to-Lymphocyte Ratio and Outcomes in Patients Admitted for Acute Heart Failure (As Seen in the BLAST-AHF, Pre-RELAX-AHF, and RELAX-AHF Studies)

The American Journal of Cardiology(2022)10.1016/j.amjcard.2022.06.037

N/A

0DataRank · unranked

34 citations

Koji Takagi, Christopher Edwards, Kirkwood F. Adams, Javed Butler, Sean P. Collins +16 more

Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events

JACC Heart Failure(2023)10.1016/j.jchf.2023.05.026

N/A

0DataRank · unranked

46 citations

Deepak L. Bhatt, Michael Szarek, Christopher P. Cannon, Lawrence A. Leiter, Darren K. McGuire +17 more

The Win Ratio Method in Heart Failure Trials: Lessons Learnt from EMPULSE

European Journal of Heart Failure(2023)10.1002/ejhf.2853

N/A

0DataRank · unranked

44 citations

João Pedro Ferreira, Timothy Collier, Christiane E. Angermann, Jan Biegus, Sean P. Collins +11 more

The Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared With Outpatients With HFrEF: An Analysis of GALACTIC-HF

Journal of Cardiac Failure(2023)10.1016/j.cardfail.2023.08.020

N/A

0DataRank · unranked

7 citations

John J.V. McMurray, Rafael Díaz, G. Michael Felker, Marco Metra, Scott D. Solomon +19 more

Dapagliflozin and Quality of Life Measured Using the EuroQol 5-Dimension Questionnaire in Patients with Heart Failure with Reduced and Mildly Reduced/Preserved Ejection Fraction

European Journal of Heart Failure(2024)10.1002/ejhf.3263

N/A

0DataRank · unranked

14 citations

Toru Kondo, Atefeh Talebi, Pardeep S. Jhund, Kieran F. Docherty, Brian Claggett +15 more

Dapagliflozin in Patients with Heart Failure and Previous Myocardial Infarction: A Participant-Level Pooled Analysis of DAPA-HF and DELIVER

European Journal of Heart Failure(2024)10.1002/ejhf.3184

N/A

0DataRank · unranked

11 citations

Muthiah Vaduganathan, Brian Claggett, Ian J. Kulac, Alberto Foà, Akshay S. Desai +17 more

Sodium-glucose co-transporter 2 inhibitors and new-onset diabetes in cardiovascular or kidney disease

European Heart Journal(2024)10.1093/eurheartj/ehae780

N/A

0DataRank · unranked

8 citations

Mats Christian Højbjerg Lassen, Brian Claggett, Zi Michael Miao, Silvio E. Inzucchi, Kieran F. Docherty +16 more

Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials

The Lancet(2025)10.1016/s0140-6736(25)01682-4

N/A

0DataRank · unranked

37 citations

Christopher M. O’Connor, Javed Butler, Ciaran J. McMullan, Kevin J. Anstrom, Irina Barash +84 more

Pathophysiology and Clinical Use of Agents with Vasodilator Properties in Acute Heart Failure. A Scientific Statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)

European Journal of Heart Failure(2025)10.1002/ejhf.3673

N/A

0DataRank · unranked

16 citations

Alexandre Mebazaa, Dimitrios Farmakis, Magdy Abdelhamid, Lars H. Lund, Veli‐Pekka Harjola +36 more